Location: Indianapolis, IndianaWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Zepbound (tirzepatide) and Mounjaro (tirzepatide)FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Eli Lilly promoted Mounjaro and Zepbound in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner, despite FDAs prior correspondence (advisory comments dated June 13, 2022 and June 21, 2022)
How do hormones, metabolism, gut health, and muscle all fit together
No randomised controlled trials have been published demonstrating efficacy in reducing disease activity, joint inflammation, or radiographic progression in patients with rheumatoid arthritis
Price: Rs 600 / VialGet Latest Price Product Brochure Product Details: Glutathione Vitamin C Glutan Injectionis an antioxidant produced in cells
References FDA approval label for Semaglutide FDA approval label for Tirzepatide Jensen TL, Brnden A, Karstoft K, Sonne DP, Christensen MB
KLOW Peptide Key Points The essential distinctions readers should understand before interpreting KLOW research claims